Key Market Indicators
Export of diagnostic reagents from Iran is set to reach $117 million by 2026, down 20% from 2021's figure of $398 million. Since 2004, the country's supply has declined by 0.4% annually. In 2021, Uruguay was ahead of Iran with $398 million, while Germany, the Netherlands and the United Kingdom occupied the second, third and fourth spots, respectively. Meanwhile, diagnostic reagent imports to Iran are expected to reach $80 million by 2026, up 3% from 2021's $68 million. Since 2002, the country's demand has grown 6.3% on average every year. Slovakia was ahead of Iran in 2021 with $68 million, and Germany, China and the Netherlands took the second, third and fourth positions, respectively.
